Financial news
Written by: Zhang Weilun
2020-02-04 10:56
Last updated: 2020-02-04 10:57The pneumonia epidemic in Wuhan is getting worse, with more than 20,000 confirmed cases worldwide and the first death in Hong Kong. As the epidemic spread, pharmaceutical stocks continued to be sought after by investors, including the announcement of its antiviral drug, which became one of the emergency strategic materials for epidemic prevention and control (0950). This morning, the gap opened 1.59 times higher. To 11 yuan, the latest reported 5.65 yuan, up 32.9%.
The company pointed out that its antiviral drug, You Jingan, was included in the “Anhui Emergency Drug Manufacturers Directory” and “Key Material Guarantee Information Monitoring Platform of the Ministry of Industry and Information Technology of the People ’s Republic of China” by Anhui Economic and Information Technology Department, becoming the epidemic situation. One of the emergency strategic materials for prevention and treatment.
In order to do a good job in the prevention and control of new coronavirus infection, the latest "Guidelines for the Public Protection of Pneumonia Infected by New Coronavirus" published by the National Center for Disease Control and Prevention of the National Health and Health Commission on January 28 and published and published. In China, interferon is listed as a new coronavirus pneumonia prevention and treatment drug. In addition, Wuhan, Shanghai and other places have listed interferon as a therapeutic drug.
[Wuhan pneumonia] U.S. stocks closed high-tech stocks led the rise of many pharmaceutical stocks
[Transferring stocks] Pharmaceutical stocks have turned around after their stocks surged
[Transferring stocks] Wuhan pneumonia raging pharmaceutical stocks continue to soar more than 60% after the resumption of trading in China Medical
Transaction stock